Clinical characteristics of subjects with a missense mutation in glucokinase.

Clinical characteristics of subjects with a missense mutation in glucokinase.

The clinical characteristics of subjects with a missense glucokinase mutation, gly299-->arg, were studied in a large pedigree, BX, initially characterized by some members having Maturity Onset Diabetes of the Young (MODY). Glucose tolerance, beta cell function and insulin sensitivity were mea...

ver descrição completa

Detalhes bibliográficos
Main Authors:	Page, R, Hattersley, A, Levy, J, Barrow, B, Patel, P, Lo, D, Wainscoat, J, Permutt, M, Bell, G, Turner, R
Formato:	Journal article
Idioma:	English
Publicado em:	1995

Registos relacionados

High prevalence of a missense mutation of the glucokinase gene in gestational diabetic patients due to a founder-effect in a local population.
Por: Saker, P, et al.
Publicado em: (1996)

Genetic testing for glucokinase mutations in clinically selected patients with MODY: a worthwhile investment
Por: S Schnyder, et al.
Publicado em: (2005-06-01)

Insights into biochemical and genetical basis of glucokinase activation from naturally occuring hypoglycaemia mutations
Por: Gloyn, A, et al.
Publicado em: (2003)

Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations.
Por: Gloyn, A, et al.
Publicado em: (2003)

Investigating novel mutational mechanisms for glucokinase mutations with near normal or paradoxical kinetics
Por: Tribble, N, et al.
Publicado em: (2009)

Availability of type II diabetic families for detection of diabetes susceptibility genes.
Por: Cook, J, et al.
Publicado em: (1993)

Identification of 21 novel glucokinase (GCK) mutations in UK and European Caucasians with maturity-onset diabetes of the young (MODY).
Por: Thomson, K, et al.
Publicado em: (2003)

Prevalence of glucokinase (GCK) mutations in people with elevated fasting glucose levels: implications for clinical trials
Por: Gloyn, A, et al.
Publicado em: (2007)

Drug resistance missense mutations in cancer are subject to evolutionary constraints.
Por: Ran Friedman
Publicado em: (2013-01-01)

Complete glucokinase deficiency is not a common cause of permanent neonatal diabetes.
Por: Gloyn, A, et al.
Publicado em: (2002)

Naturally occurring glucokinase mutations are associated with defects in posttranslational S-nitrosylation.
Por: Ding, S, et al.
Publicado em: (2010)

Association of low birth weight with beta cell function in the adult first degree relatives of non-insulin dependent diabetic subjects.
Por: Cook, J, et al.
Publicado em: (1993)

Distribution of type II diabetes in nuclear families.
Por: Cook, J, et al.
Publicado em: (1993)

Novel glucokinase mutation in a boy with maturity-onset diabetes of the young
Por: Milenković Tatjana, et al.
Publicado em: (2008-01-01)

Glucokinase (GCK) mutations and their characterization in MODY2 children of southern Italy.
Por: Marina Capuano, et al.
Publicado em: (2012-01-01)

The role of genetic variation in glucokinase and glucokinase regulatory protein in diabetes and related traits
Por: Beer, N, et al.
Publicado em: (2011)

The previously reported T342P GCK missense variant is not a pathogenic mutation causing MODY
Por: Steele, A, et al.
Publicado em: (2011)

The previously reported T342P GCK missense variant is not a pathogenic mutation causing MODY.
Por: Steele, A, et al.
Publicado em: (2011)

Naturally occurring glucokinase mutations at the same amino acid residue cause opposite clinical phenotypes of hypo- and hyperglycaemia
Por: Beer, N, et al.
Publicado em: (2010)

Identification and functional characterisation of novel inactivating glucokinase mutations causing GCK-MODY in Slovakia
Por: Valentinova, L, et al.
Publicado em: (2011)

Identification of a novel beta cell glucokinase (GCK) promoter mutation (-71 G > C) which reduces promoter activity
Por: Gasperikova, D, et al.
Publicado em: (2008)

Gene characteristics predicting missense, nonsense and frameshift mutations in tumor samples
Por: Ivan P. Gorlov, et al.
Publicado em: (2018-11-01)

Association of glucokinase, glucokinase regulator, glucose-6-phosphatase catalytic subunit 2 and melatonin receptor 1b genes polymorphisms with type 2 diabetic subjects
Por: Ansari, Neda
Publicado em: (2020)

Identification of novel and recurrent glucokinase mutations in Belgian and Luxembourg maturity onset diabetes of the young patients.
Por: Vits, L, et al.
Publicado em: (2006)

Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young.
Por: Gloyn, A, et al.
Publicado em: (2005)

Citrullination of glucokinase is linked to autoimmune diabetes
Por: Mei-Ling Yang, et al.
Publicado em: (2022-04-01)

A Rare Nonsense Mutation in the Glucokinase Regulator Gene Is Associated With a Rapidly Progressive Clinical Form of Nonalcoholic Steatohepatitis
Por: Carlos J. Pirola, et al.
Publicado em: (2018-09-01)

Segregation analysis of NIDDM in Caucasian families.
Por: Cook, J, et al.
Publicado em: (1994)

Specific insulin and proinsulin secretion in glucokinase-deficient individuals
Por: V.C. Pardini, et al.
Publicado em: (1999-04-01)

Genetic and clinical characteristics of Chinese children with Glucokinase-maturity-onset diabetes of the young (GCK-MODY)
Por: Li, Xiuzhen, et al.
Publicado em: (2018)

Genetic and clinical characteristics of Chinese children with Glucokinase-maturity-onset diabetes of the young (GCK-MODY)
Por: Xiuzhen Li, et al.
Publicado em: (2018-03-01)

Variable phenotypes are associated with PMP22 missense mutations.
Por: Russo, M, et al.
Publicado em: (2011)

Clinical investigation of glucokinase activators for the restoration of glucose homeostasis in diabetes
Por: Ping Li, et al.
Publicado em: (2024-05-01)

Identification and functional characterisation of novel glucokinase mutations causing maturity-onset diabetes of the young in Slovakia.
Por: Valentinova, L, et al.
Publicado em: (2012)

Conformational transition pathway of R308K mutant glucokinase in the presence of the glucokinase activator YNKGKA4
Por: Nanda Kumar Yellapu, et al.
Publicado em: (2018-08-01)

Near-normalisation of diurnal glucose concentrations by continuous administration of glucagon-like peptide-1 (GLP-1) in subjects with NIDDM.
Por: Rachman, J, et al.
Publicado em: (1997)

Precision medicine in diabetes: A non‐invasive prenatal diagnostic test for the determination of fetal glucokinase mutations
Por: Thierry Nouspikel, et al.
Publicado em: (2022-02-01)

Predicting the effect of missense mutations on protein function: analysis with Bayesian networks
Por: Care Matthew A, et al.
Publicado em: (2006-09-01)

Multiple Property Tolerance Analysis for the Evaluation of Missense Mutations
Por: Tai-Sung Lee, et al.
Publicado em: (2006-01-01)

Permanent neonatal diabetes mellitus in an Indian infant due to a novel mutation in the glucokinase gene
Por: Kagithapu Surender, et al.
Publicado em: (2021-01-01)